Premium
Quantification of intact human insulin‐like growth factor‐I in serum by nano‐ultrahigh‐performance liquid chromatography/tandem mass spectrometry
Author(s) -
Lopes Filipe,
Cowan David A.,
Thevis Mario,
Thomas Andreas,
Parkin Mark C.
Publication year - 2014
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.6908
Subject(s) - chemistry , chromatography , mass spectrometry , protein precipitation , electrospray ionization , detection limit , liquid chromatography–mass spectrometry , tandem mass spectrometry , selected reaction monitoring , insulin like growth factor , electrospray , growth factor , biochemistry , receptor
RATIONALE Insulin‐like growth factor‐I is one of the biomarkers used to detect growth hormone administration prohibited in human sport. Current testing approaches for IGF‐I rely on commercial immunoassays, which may change from time to time requiring complex revalidation. Mass spectrometry (MS)‐based approaches often rely on enzymatically digesting the protein and measuring specific peptide concentrations. In order to reinforce the current available methodology for IGF‐I testing, a reliable and equally sensitive MS method is required for the analysis of intact protein using small sample volumes (<25 μL). METHODS IGF‐I was extracted from human serum samples by a simple protein precipitation procedure. Separation was achieved via nano‐ultrahigh‐performance liquid chromatography and MS analysis was conducted by nano‐electrospray ionisation triple‐quadrupole mass spectrometry in the selected reaction monitoring mode using a stable‐isotope‐labelled internal standard. RESULTS A six‐point calibration curve ranging from 50 to 1000 ng/mL of human IGF‐I in rat serum was used to establish instrument response. The method provided a limit of quantification of 50 ng/mL, with intra‐ and inter‐day precision ≤5% and intra‐ and inter‐day accuracy ≥95%. CONCLUSIONS A quantitative method was developed for the quantification of intact IGF‐I in human serum samples. The data generated provided important information for the development of a new reference method for the growth hormone biomarker test and helped create a reliable system for monitoring peptide hormones in individual athletes, a possible extension to the athlete biological passport system. Nano‐electrospray has here been shown to be sufficiently robust for routine use in an analytical laboratory, allowing for the analysis of minute sample volumes. Copyright © 2014 John Wiley & Sons, Ltd.